AU455699B2 - Novel compound forthe treatment of cardiovascular disorders and pharmaceutical compositions containing thesame - Google Patents

Novel compound forthe treatment of cardiovascular disorders and pharmaceutical compositions containing thesame

Info

Publication number
AU455699B2
AU455699B2 AU40002/72A AU4000272A AU455699B2 AU 455699 B2 AU455699 B2 AU 455699B2 AU 40002/72 A AU40002/72 A AU 40002/72A AU 4000272 A AU4000272 A AU 4000272A AU 455699 B2 AU455699 B2 AU 455699B2
Authority
AU
Australia
Prior art keywords
papaverine
composition
adenosine
compound
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU40002/72A
Other languages
English (en)
Other versions
AU4000272A (en
Inventor
Yves Mauvernay Roland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre Europeen de Recherches Mauvernay CERM
Original Assignee
Centre Europeen de Recherches Mauvernay CERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Europeen de Recherches Mauvernay CERM filed Critical Centre Europeen de Recherches Mauvernay CERM
Publication of AU4000272A publication Critical patent/AU4000272A/en
Application granted granted Critical
Publication of AU455699B2 publication Critical patent/AU455699B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AU40002/72A 1971-03-16 1972-03-15 Novel compound forthe treatment of cardiovascular disorders and pharmaceutical compositions containing thesame Expired AU455699B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FRFR71.09044 1971-03-16
FR7109044A FR2129833B1 (enExample) 1971-03-16 1971-03-16

Publications (2)

Publication Number Publication Date
AU4000272A AU4000272A (en) 1973-09-20
AU455699B2 true AU455699B2 (en) 1974-11-07

Family

ID=9073583

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40002/72A Expired AU455699B2 (en) 1971-03-16 1972-03-15 Novel compound forthe treatment of cardiovascular disorders and pharmaceutical compositions containing thesame

Country Status (7)

Country Link
US (1) US3823234A (enExample)
JP (1) JPS5128686B1 (enExample)
AU (1) AU455699B2 (enExample)
DE (1) DE2212840A1 (enExample)
ES (1) ES400785A1 (enExample)
FR (1) FR2129833B1 (enExample)
GB (1) GB1336419A (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2257277B1 (enExample) * 1974-01-16 1978-02-03 Choay Sa
DE2717001C2 (de) * 1977-04-18 1984-06-20 Karl O. Helm Ag, 2000 Hamburg Arzneimittel mit antithrombotischer Wirkung
US4267182A (en) * 1979-01-16 1981-05-12 The United States Of America As Represented By The Secretary Of The Army Narcotic antagonists in the therapy of shock
US5104859A (en) * 1985-09-24 1992-04-14 Solimedco Aktiebolag Continuous administration of adenosine to reduce pulmonary vascular resistance
ATE84419T1 (de) * 1985-09-24 1993-01-15 Item Dev Ab Kontinuierliche intravenoese infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln.
US4923851A (en) * 1987-12-29 1990-05-08 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US5665731A (en) * 1995-06-07 1997-09-09 Hennessey; Richard K. Method and composition for treating with a vasodilator inflammation, bone loss and detachment of teeth as associated with periodontal
US20040258668A1 (en) * 2001-09-27 2004-12-23 Makoto Inoue Method for regulating the expression of genes carried on a viral vector

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131923C (enExample) * 1966-02-25
GB1186863A (en) * 1966-06-06 1970-04-08 Prodotti Antibiotici Spa Salts of 6-Phosphogluconic Acid and Pharmaceutical Compositions containing 6-Phosphogluconic Acid or Salts thereof

Also Published As

Publication number Publication date
FR2129833A1 (enExample) 1972-11-03
AU4000272A (en) 1973-09-20
JPS5128686B1 (enExample) 1976-08-20
GB1336419A (en) 1973-11-07
ES400785A1 (es) 1976-02-01
FR2129833B1 (enExample) 1974-08-02
DE2212840A1 (de) 1972-10-05
US3823234A (en) 1974-07-09

Similar Documents

Publication Publication Date Title
CA959366A (en) Compositions of matter
AU461461B2 (en) Photo-polymerizable compositions and method of preparation
CA987598A (en) Cleansing of dentures
CA989864A (en) Metal derivatives of 3,5-di-t-butyl-hydroxyphenylpropionic acid and compositions containing these derivatives
AU4000272A (en) Novel compound forthe treatment of cardiovascular disorders and pharmaceutical compositions containing thesame
CA963204A (en) Treatment of pigments
AU451333B2 (en) Treatment of arabinogalactan
AU472168B2 (en) Treatment of titanium
CA950833A (en) Composition for the treatment of hypertrophied oral tissue
CA987321A (fr) Isopropyl-2-tetrahydro oxazines-1,3 substituees, leur procede de preparation et leur application en therapeutique
IL37798A0 (en) Novel fluoro-steroids of thepregnane series and pharmaceutical compositions containing them
CA1003827A (en) Compounds of spiro-amine type and methods for their preparation
AU463836B2 (en) Composition for treatment of asthma
AU4836072A (en) Preparation of 2 (ih0-quinazolinones
ZA724724B (en) Pharmaceutical compositions for treatment of bronchial diseases
AU464275B2 (en) Pharmaceutical compositions comprising esters of 9-fluoro-16-methylene-prednisolone
AU462801B2 (en) Organopolysiloxane composition andthe treatment of substrates therewith
CA975980A (en) Treatment of solids
AU451013B2 (en) Compositions of substituted guanidines and method of use thereof
AU453644B2 (en) Compositions of matter
AU456621B2 (en) Treatment of pigments
AU423068B2 (en) Prophylaxis and treatment of cardiac disorders
AU459945B2 (en) Treatment of keratinous substrates
CA982421A (en) Manufacture of microglobules
CA884276A (en) Therapeutic composition containing members of hexanehexols and disacharides